Laboratory Corp of America Holdings Stock News

A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

LH, $257.94; Market Capitalization: $23.3 billion), a leading global life sciences company, announced that its Board of Directors authorized a plan to spin-off Clinical Development business into an in

Keybanc cut the price target on Airbnb, Inc. (NASDAQ: ABNB) from $195 to $145. However, Keybanc analyst Justin Patterson maintained the stock with an Overweight. Airbnb shares rose 0.7% to $111.70 i

After a drop of about 20% in the first six months of this year, investors feel nervous even though July has been good.

Over the past 3 months, 4 analysts have published their opinion on Laboratory Corp (NYSE:LH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a com

LH earnings call for the period ending June 30, 2022.

LabCorp (LH) posts better-than-expected earnings in the second quarter and demonstrates continued strength in the organic Base Business.

Laboratory Corporation of America Holdings (NYSE:LH ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Chas Cook - VP, IR Adam Schechter - President, CEO & Chairman Glenn

LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LabCorp (LH) delivered earnings and revenue surprises of 6.21% and 3.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Shares of Labcorp LH, +1.03% gained 4.2% in premarket trading on Thursday after beating earnings expectations for the second quarter and announcing plans to spin off its clinical-development business,

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, TMO and BIO will likely fare this time.

AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.

LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.